Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. A heath check for Scotland’s pharmaceutical industry
  2. Pharma Technology Focus: Scottish pharma gets a health check
  3. MHRA recalls a further three batches of sartan-based products
  4. No-deal Brexit could put UK patients at risk of fake medicines
  5. FDA returns to work post-shutdown, but February funding lapse looms

Latest Content

A heath check for Scotland’s pharmaceutical industry

Despite being a major contributor to the economy, the pharmaceutical industry in Scotland has experienced a decline since 2012 when R&D spending and employment began to drop. But, as new figures suggest the beginning of a turnaround, is there cause to be optimistic for the industry’s future?

MHRA recalls a further three batches of sartan-based products

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as part of its continued investigation into potential N-nitrosodiethylamine (NDEA) contamination of sartan-containing medicines, which are indicated for high blood pressure and heart attacks.

Pharmaceutical packaging in 2019: the view from Origin’s Rich Quelch

The pharmaceutical packaging market is always challenging and 2019 will be no exception. What will rising demand from emerging economies, ageing demographics, new technologies and drug discoveries mean for pharmaceutical packaging in 2019? Rich Quelch, Global Head of Marketing, Origin gives his predictions.

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top